Amedisys, Inc.
AMED
Clasificación en acciones
#4610
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Precio por acción
$100.99
Última sincronización: 2025-08-15
Capitalización bursátil
$3.31B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Amedisys, Inc. (AMED)
Categoría
Healthcare
Ratio P/E de Amedisys, Inc. (AMED)
Ratio P/E al October 2026 TTM: 76.51
Según los últimos informes financieros y el precio de las acciones de Amedisys, Inc., el P/E actual (TTM) de la empresa es 76.51. Al final de 2023, la empresa tenía un P/E de -316.87.
Historial del ratio P/E de Amedisys, Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 76.51 | 11.35% |
| 2024 | 68.71 | -121.68% |
| 2023 | -316.87 | -1,483.53% |
| 2022 | 22.90 | -9.38% |
| 2021 | 25.27 | -51.41% |
| 2020 | 52.02 | 22.97% |
| 2019 | 42.30 | 31.46% |
| 2018 | 32.18 | -45.12% |
| 2017 | 58.63 | 54.36% |
| 2016 | 37.98 | -108.84% |
| 2015 | -429.75 | -679.14% |
| 2014 | 74.20 | -1,661.37% |
| 2013 | -4.75 | 17.52% |
| 2012 | -4.04 | 394.07% |
| 2011 | -0.82 | -109.81% |
| 2010 | 8.34 | -14.38% |
| 2009 | 9.74 | -22.75% |
| 2008 | 12.61 | -34.51% |
| 2007 | 19.26 | 2.76% |
| 2006 | 18.74 | -14.43% |
| 2005 | 21.90 | 6.17% |
| 2004 | 20.63 | 16.62% |
| 2003 | 17.69 | -74.09% |
| 2002 | 68.26 | 784.09% |
| 2001 | 7.72 | 161.14% |
| 2000 | 2.96 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 15.70 | -79.48% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -86.41% |
US
|
|
| 32.07 | -58.08% |
SA
|
|
| 20.00 | -73.86% |
BR
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.